Title : Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers & Non-smokers in Different Doses.

Pub. Date : 2022 Mar-Apr

PMID : 35480532






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers & Non-smokers in Different Doses. rasagiline cytochrome P450 family 1 subfamily A member 2 Homo sapiens
2 Objectives: Rasagiline, a drug for Parkinson"s disease is metabolized by CYP1A2 enzyme. rasagiline cytochrome P450 family 1 subfamily A member 2 Homo sapiens
3 The objective of the study was to investigate the influence of cytochrome P450 1A2 variants and smoking status of healthy individuals on the pharmacokinetics of rasagiline. rasagiline cytochrome P450 family 1 subfamily A member 2 Homo sapiens
4 Conclusion: The study concludes that the systemic metabolism of rasagiline is significantly increased in CYP1A2*AA variants while smoking status did not show consistent difference in PK parameters. rasagiline cytochrome P450 family 1 subfamily A member 2 Homo sapiens